Texas-based USMD Holdings, Inc. (NASDAQ: USMD), a physician-led integrated healthcare system, sold its division US Lithotripsy LP, to United Medical Systems (UMS), for $19.8 million in cash.
UMS is a leading provider of mobile medical equipment and services, including urology, women’s health and MRI imaging, to hospitals, surgery centers and physician offices across the U.S., Canada and South America. The company is owned by private equity firm New State Capital Partners.
US Lithotripsy adds more than 100 hospitals, ambulatory surgical centers and other sites of service in the southwestern United States to UMS’ mobile lithotripsy customer base. The majority of these facilities are based in Arizona, Arkansas, Colorado, Missouri, Oklahoma and Texas. US Lithotripsy performs over 12,000 ESWL procedures annually.
Lithotripsy is a non-surgical procedure that typically uses ultrasound shock waves to break up stones in the kidney, bladder, or ureter. After the procedure, the tiny stone particles can be passed out by the body in the urine.
“Although the lithotripsy division has been an extremely valuable part of USMD Health System, this transaction allows USMD to focus on our efforts on continuing to deliver world-class, cost-effective healthcare to patients in our clinics, hospitals, and cancer treatment centers, and solidifying our position as one of the leading health systems in the DFW Metroplex,” said John House, CEO and chairman of USMD Holdings.
“UMS is excited to add the USMD lithotripsy division to our line-up of mobile medical services,” said Jorgen Madsen, president and CEO of UMS. “We view this opportunity to expand our lithotripsy services as an important part of our commitment to continually offer our clients increased access to superior technology. The acquisition of USMD’s lithotripsy division is a continuation of our mission to achieve a nationwide footprint for our transportable medical services. We are excited to welcome the USMD lithotripsy division to our family.”
Prior to the acquisition, USMD had in excess of 20 lithotripsy ventures, in syndication, mobilizing 28 lithotripters in 10 states and performing more than 12,000 extracorporeal shock wave lithotripsy procedures annually. After the acquisition, USMD retained sixty percent of its ownership in Metro I Stone Management, Ltd., a Texas limited partnership which operates in the D/FW market.
Headquartered in Irving, Texas, USMD serves the Dallas-Fort Worth metropolitan area with more than 250 physicians and associate practitioners, and provides healthcare services to patients in just under 20 different specialties at its two hospitals, four cancer treatment centers and more than 50 physician clinics, many of which are multi-specialty. All 29 of USMD’s primary care clinics have been accredited by the Patient-Centered Medical Home Program, a recognition program that is part of the National Committee for Quality Assurance.
UMS provides affordable, advanced mobile medical services. Its unique transportable platform offers the appearance of a full-time, in-house program, without incurring the cost and burden associated with a fixed program. United Medical Systems pioneered the concept of shared mobile medical services – Lithotripsy and Stereotactic Breast Biopsy – and has become an international leader by partnering with medical facilities ranging from hospitals, ambulatory surgery center and physician offices to medical equipment manufacturers. UMS transports equipment into and out of procedure suites on a daily basis and has performed more than 650,000 procedures. UMS is an internationally recognized company servicing over 850 facilities across the United States, as well as operating in Canada and South America – Chile and Peru.
New State Capital Partners, LLC is an entrepreneurial-minded private equity firm with $250 million in assets under management. The firm invests in market-leading companies with $8 million to $30 million of EBITDA in the areas of business services, healthcare services and industrials. The firm was founded by David Blechman in 2013, and is based in New York City, with additional offices in Larchmont, NY and Dallas, TX.